Gibson Dunn, Latham advise in $3.4B medical device deal
Gibson, Dunn & Crutcher LLP represented St. Jude Medical Inc. in its $3.4 billion
acquisition of Thoratec Corp., which designs, manufactures and sells products that
treat heart failure.
The boards of directors of both companies have unanimously approved the agreement,
which allow...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In